Crossmark

Tumor-on-a-chip platforms to study cancer–immune system crosstalk in the era of immunotherapy

Crossref DOI link: https://doi.org/10.1039/D0LC00799D

Published Online: 2021

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Parlato, Stefania

Grisanti, Giulia

Sinibaldi, Giorgia

Peruzzi, Giovanna

Casciola, Carlo Massimo

Gabriele, Lucia https://orcid.org/0000-0002-1483-866X
Funding

Funding for this research was provided by:

Ministero della Salute (2 - 8ARC)

H2020 European Research Council (779751)
License Information

Accepted Manuscript valid from 2021-11-19
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Lucia Gabriele (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 7 August 2020; Accepted 18 November 2020; Accepted Manuscript published 19 November 2020; Advance Article published 14 December 2020; Version of Record published 27 January 2021